An Australia-based biotech company Mesoblast announced that it has began clinical trials for its stem cell therapy remestemcel-L in the treatment of COVID-19 patients experiencing Acute Respiratory Distress Syndrome (ARDS). Mesoblast’s remestemcel-L treatment is derived from allogenic mesenchymal stem cells, which when infused into the body can slow down an immune response and prevent the body […]
The post Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon appeared first on MojiDelano.Com.
Tags:
entertainment